GAIN THERAPEUTICS, INC Debt Securities Available For Sale And Held To Maturity Fair Value
GAIN THERAPEUTICS, INC (GANX) had Debt Securities Available For Sale And Held To Maturity Fair Value of $14.77 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale and Held-to-Maturity, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue · last filed 2022-11-10
- 2022-09-30: Debt Securities Available For Sale And Held To Maturity Fair Value $14.77M.
- 2022-06-30: Debt Securities Available For Sale And Held To Maturity Fair Value $14.86M.
| Period end | Debt Securities Available For Sale And Held To Maturity Fair Value |
|---|---|
| 2022-09-30 | $14.77M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $14.86M 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |